Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ShockPulse-SE Lithotripsy System

K-Number: K171024 · 2017-08-21

Decision Date2017-08-21
Product CodeFEO
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

ShockPulse-SE Lithotripsy System is the device name listed in this FDA 510(k) record. The listed applicant is Cybersonics, Inc.. It received FDA 510(k) clearance on 2017-08-21 under 510(k) number K171024. The device is classified under product code FEO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ShockPulse-SE Lithotripsy System?

ShockPulse-SE Lithotripsy System is a medical device that received FDA 510(k) clearance on 2017-08-21. The listed applicant is Cybersonics, Inc.. The 510(k) number is K171024.

When did ShockPulse-SE Lithotripsy System receive FDA 510(k) clearance?

ShockPulse-SE Lithotripsy System received FDA 510(k) clearance on 2017-08-21, under 510(k) number K171024.

Who is the listed applicant for ShockPulse-SE Lithotripsy System?

The FDA 510(k) record lists Cybersonics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ShockPulse-SE Lithotripsy System?

The FDA product code for ShockPulse-SE Lithotripsy System is FEO.

Related Devices (Code: FEO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.